Models for Evidence Generation During the COVID-19 Pandemic: New Opportunities for Clinical Trials in Cardiovascular Medicine
Circulation
.
2023 Jan 17;147(3):187-189.
doi: 10.1161/CIRCULATIONAHA.122.061231.
Epub 2023 Jan 17.
Author
Patrick R Lawler
1
Affiliation
1
Peter Munk Cardiac Centre, Toronto General Hospital; and Division of Cardiology and Interdepartmental Division of Critical Care Medicine, University of Toronto, Canada.
PMID:
36649393
PMCID:
PMC9842096
DOI:
10.1161/CIRCULATIONAHA.122.061231
No abstract available
Keywords:
COVID-19; clinical trial; pandemics.
MeSH terms
COVID-19*
Cardiovascular Agents*
Humans
Pandemics
Research Design
SARS-CoV-2
Substances
Cardiovascular Agents